Nitric oxide (NO) released from nonadrenergic-noncholinergic (NANC) ne
rves seems to be a principal mediator of the relaxation of penile erec
tile tissue necessary for erection, and drugs acting by release of NO
have been shown to produce el:ection when injected intracorporeally in
to impotent patients. By producing hyperpolarization, K+ channel opene
rs are effective in relaxing isolated penile erectile tissue from rabb
it and man, and can produce tumescence and erection when injected intr
acorporeally into animals. Nicorandil is classified as a K+ channel op
ener, but it also acts as a donor of NO. In the present study, the eff
ects of nicorandil on isolated preparations from human corpus cavernos
um (CC) and deep cavernous artery (Ace) were compared with those of cr
omakalim (K+ channel opener) and SIN-1 (NO donor). Nicorandil produced
a concentration-dependent relaxation of CC and Ace preparations. The
relaxations obtained at the highest nicorandil concentration used (10(
-4) M.) were 75 +/- 3% and 66 +/- 4% in CC preparations contracted by
noradrenaline and endothelin-l, respectively. The corresponding effect
s in Ace preparations were 70 +/- 14% and 73 +/- 5%. Glibenclamide (bl
ocking ATP-dependent K+ channels) significantly reduced the nicorandil
-induced relaxation in CC, but not in Ace. Methylene blue (believed to
block soluble guanylate cyclase) reduced nicorandil's relaxant effect
in CC, although statistical significance was not obtained. NG-nitro-L
-arginine 10(-4) M. (NO synthase inhibitor) did not significantly infl
uence the effect of nicorandil on precontracted preparations in either
tissue. In CC preparations contracted by electrical field stimulation
, nicorandil and cromakalim concentration dependently inhibited the re
sponses. This effect was significantly counteracted by glibenclamide.
It is concluded that nicorandil is effective in relaxing human CC chie
fly by its K+ channel opening action, and to some extent by its abilit
y to release NO. For nicorandil's relaxing effect on Ace, ATP dependen
t K+ channels seem to be of limited importance. If effective in impote
nt patients, the drug may represent a new, interesting approach to the
treatment of erectile dysfunction.